Evidence suggests that overexpression hsa-miR-1277 could ameliorate IL-1β-induced CHON-001 cell injury and inhibit the progression of Parkinson’s disease [64, 65], but these studies were all in vitro. This evidence concerns the gene IL1B and Parkinson disease.